Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Regulatory News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 296.50
Bid: 297.50
Ask: 300.00
Change: -6.00 (-1.98%)
Spread: 2.50 (0.84%)
Open: 313.00
High: 313.50
Low: 296.50
Prev. Close: 302.50
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

20 Feb 2007 12:45

Oxford Biomedica PLC20 February 2007 TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES 1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii): Oxford BioMedica PLC 2. Reason for the notification (please state Yes/No): ( ) An acquisition or disposal of voting rights: (Yes) An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: ( ) An event changing the breakdown of voting rights: ( ) Other (please specify) : ( ) 3. Full name of person(s) subject to the notification obligation (iii): Barclays plc 4. Full name of shareholder(s) (if different from 3.) (iv): Barclays Capital Securities Ltd Barclays Global Investors Ltd Barclays Life Assurance Co Ltd Barclays Private Bank and Trust Ltd Barclays Stockbrokers Ltd Gerrard Ltd 5. Date of the transaction (and date on which the threshold is crossed or reached if different) (v): 16 February 2007 6. Date on which issuer notified: 19 February 2007 7. Threshold(s) that is/are crossed or reached: 6% to 5% 8. Notified details: A: Voting rights attached to shares Class/type of shares Situation previous to the Triggering transaction (vi)if possible using the ISIN CODE Number of shares Number of voting Rights (viii)GB0006648157 30,117,945 30,117,945 Resulting situation after the triggering transaction (vii)Class/type of shares Number of Number of % of voting rightsif possible using shares voting rights (ix) the ISIN CODE Direct Direct (x) Indirect (xi) Direct Indirect GB0006648157 29,868,965 - 29,868,965 - 5.95% B: Financial Instruments Resulting situation after the triggering transaction (xii)Type of Expiration Date Exercise/Conversion Number of voting % of votingfinancial (xiii) Period/Date (xiv) rights that may be rightsinstrument acquired if the instrument is exercised/ converted.N/A N/A N/A N/A N/A Total (A+B)Number of voting rights % of voting rights 29,868,965 5.95% 9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xv): Registered Holder Holding % Barclays plc 29,868,965 5.95% Barclays Capital Securities Ltd Barclays Global Investors Ltd Barclays Life Assurance Co Ltd Barclays Private Bank and Trust Ltd Barclays Stockbrokers Ltd Gerrard Ltd Proxy Voting: 10. Name of the proxy holder: N/A 11. Number of voting rights proxy holder will cease to hold: N/A 12. Date on which proxy holder will cease to hold voting rights: N/A 13. Additional information: None 14. Contact name: Andrew Wood 15. Contact telephone number: 01865 783000 Annex to Notification Of Major Interests In Shares (xvi) A: Identity of the person or legal entity subject to the notification obligation Full name (including legal form for legal entities):Barclays plc Contact address (registered office for legal entities):1 Churchill Place, London, E14 5HP Phone number:020 7116 2913 Other useful information (at least legal representative for legal persons):N/A B: Identity of the notifier, if applicable (xvii) Full name:Geoff Smith Contact address:Barclays Compliance1 Churchill Place, London, E14 5HP Phone number:020 7116 2913 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Sep 20237:00 amRNSInterim results
1st Sep 20237:00 amRNSTotal Voting Rights
22nd Aug 20237:00 amRNSExpanded agreement with Cabaletta Bio
14th Aug 20237:00 amRNSNotice of Interim Results
1st Aug 20237:00 amRNSTotal Voting Rights
3rd Jul 20234:31 pmRNSPDMR Dealings
3rd Jul 20237:00 amRNSOxford Biomedica PLC - Block Listing Return
3rd Jul 20237:00 amRNSTotal Voting Rights
23rd Jun 20235:32 pmRNSResult of AGM
6th Jun 20233:59 pmRNSTotal Voting Rights
15th May 20237:00 amRNSOxford Biomedica launches TetraVecta system
10th May 20237:00 amRNSBlock listing Application
5th May 20237:00 amRNS2023 AGM Notification
2nd May 20237:00 amRNSTotal Voting Rights
28th Apr 20237:59 amRNS2022 Annual Report and Accounts
26th Apr 20237:00 amRNSBoard Appointment
25th Apr 20237:00 amRNSPreliminary results for the year ended 31 Dec 2022
19th Apr 20236:26 pmRNS2022 Preliminary results revised date
3rd Apr 20231:19 pmRNSTotal Voting Rights
30th Mar 20237:00 amRNSNotice of Preliminary Results
13th Mar 202311:33 amRNSOXB confirms no exposure to SVB receivership
1st Mar 202311:16 amRNSTotal Voting Rights
20th Feb 20237:00 amRNSDr Frank Mathias to join as new CEO on 27 March
1st Feb 202310:18 amRNSTotal Voting Rights
27th Jan 20237:00 amRNSBoard Change
3rd Jan 20235:19 pmRNSBlock listing return
3rd Jan 202311:28 amRNSTotal Voting Rights
21st Dec 202212:00 pmRNSOxford Biomedica to Present at J.P Morgan
14th Dec 20227:00 amRNSOxford Biomedica Solutions forms new partnerships
22nd Nov 20227:00 amRNSOxford Biomedica Appoints Frank Mathias as CEO
15th Nov 20222:35 pmRNSHolding(s) in Company
14th Nov 20227:00 amRNSSale and leaseback of Windrush Court facility
1st Nov 20229:14 amRNSTotal Voting Rights
14th Oct 20222:28 pmRNSPDMR Dealings
12th Oct 20227:00 amRNSPDMR Dealings
12th Oct 20227:00 amRNSPDMR Dealings
7th Oct 20221:16 pmRNSPDMR Dealing Amendment
7th Oct 202212:28 pmRNSPDMR Dealing
7th Oct 20227:00 amRNSAmendment of Short-Term Loan Facility
3rd Oct 20229:34 amRNSTotal Voting Rights
15th Sep 20227:00 amRNSInterim Results
14th Sep 20227:00 amRNSOxford Biomedica Solutions signs new partner
7th Sep 20227:00 amRNSLicence & Supply Agreement with New Partner
1st Sep 20229:51 amRNSTotal Voting Rights
25th Aug 20227:00 amRNSNotice of Interim Results
16th Aug 20227:00 amRNSOxford Biomedica Notes Homology Q2 Report
1st Aug 20229:42 amRNSTotal Voting Rights
27th Jul 20227:00 amRNSAppointment of Joint Corporate Broker
26th Jul 20227:00 amRNSLicence & Supply Agreement with New Partner
26th Jul 20227:00 amRNSNew Project with Orchard Therapeutics

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.